NYSE:RNN
Delisted

Rexahn Pharmaceuticals Stock Signals

etoro logo Buy RNN
*Your capital is at risk
$5.24
+0 (+0%)
At Close: Sep 19, 2019

Latest Data & Signals Issued

Below are some of the latest signals issued for Rexahn Pharmaceuticals, Inc.

General

Signal Type Signal Value Data
Score 0.000 41 days ( 0 %
Last Price $5.24 0 %
Performance History
7 Days
$5.24 $5.24
0%
30 Days
$5.24 $5.24
0%
12 Mos
$1.83 $5.24
186.34%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 20.95
Signal Type Signal Value Importance Data
High / Low N/A Very Low $5.24 - $5.24
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Sep 18, 2019 - 2 days
RSI Short Pivot Signal Buy Very Low Jun 24, 2019 - 62 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Jul 25, 2019 - 40 days
Short/Long MA 3 mos Sell Medium Jul 25, 2019 - 40 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 42.91
Signal Type Signal Value Importance Data
Trend - 12 mos 176.48 % Very High Width: 200.46 %
Pred. range - 12 mos $8.56 - $25.73 High 63.42 % - 391.02 %
Short MA 12 mos Sell Very High Jun 21, 2019 - 63 days
Long MA 12 mos Sell Very High Aug 29, 2019 - 15 days
Short/Long MA 12 mos Sell Very High Aug 29, 2019 - 15 days
Pivot Long Buy Low Jun 05, 2019 - 75 days
RSI Long Pivot Signal Buy Low Jul 03, 2019 - 55 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT REXAHN PHARMACEUTICALS, INC.
Rexahn Pharmaceuticals
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes treatments for cancer. The company’s clinical stage oncology candidates include Archexin that completed a pilot Phase IIa clinical trial for the treatment of pancreatic cancer; RX-3117, which is in Phase Ib clinical trial for the treatment of patients with solid tumors; and Supinoxin that is in Phase I clinical trial for patients wit...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
4.95% Jun 05
TPR
$140.47
0.320% Jun 04
N
NVRI
$19.53
4.92% May 20
GLBE
$31.61
3.54% May 05
FIZZ
$34.11
8.80% May 01

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE